AbbVie Inc . ABBV announced a label expansion for its anti inflammatory drug, Humira, in the U.S. With the label expansion, Humira can now be used for the treatment of patients suffering from moderate to severe hidradenitis suppurativa (HS).
AbbVie's Humira Gains FDA Approval for Label Expansion
